Cushman WC, Davis BR, Pressel SL, et al. Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial[J]. J Clin Hypertens (Greenwich), 2012, 14(1): 20-31.
[2]
Wassertheil-Smoller S, Psaty B, Greenland P, et al. Association between cardiovascular outcomes and antihypertensive drug treatment in older women[J]. JAMA, 2004, 292(23): 2849-2859.
[3]
Yasar S, Lin FM, Fried LP, et al. Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory study[J]. Alzheimers Dement, 2012, 8(3): 188-195.
[4]
Kooter AJ, Smulders YM. Chlorthalidone better than hydrochlorothiazide in hypertension[J]. Ned Tijdschr Geneeskd, 2010, 154: A1608.
[5]
Dorsch MP, Gillespie BW, Erickson SR, et al. Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis[J]. Hypertension, 2011, 57(4): 689-694.
[6]
Chow KM, Szeto CC, Wong TY, et al. Risk factors for thiazide-induced hyponatremia[J]. Q J M, 2003, 96(12): 911-917.
[7]
Sharabi Y, Illan R, Kamari Y, et al. Diuretic induced hyponatraemia in elderly hypertensive women[J]. J Hum Hypertens, 2002, 16(9): 631-635.
[8]
Takahashi Y, Nishida Y, Nakayama T, et al. Adverse effect profile of trichlormethiazide: a retrospective observational study[J]. Cardiovascular Diabetology, 2011, 10: 45.
[9]
Choi HK, Soriano LC, Zhang Y, et al. Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study[J]. BMJ, 2012, 344: d8190.
Greenberg A. Diuretic complications[J]. Am J Med Sci, 2000, 319(1): 10-24.
[13]
Carter BL, Einhorn PT, Brands M, et al. Thiazide-induced dysglycemia : call for research from a working group from the national heart, lung, and blood institute[J]. Hypertension, 2008, 52(1): 30-36.
[14]
Helderman JH, Elahi D, Andersen DK, et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium[J]. Diabetes, 1983, 32(2): 106-111.
[15]
Zillich AJ, Garg J, Basu S, et al. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review[J]. Hypertension, 2006 , 48(2): 219-224.
[16]
Ellison DH, Loffing J. Thiazide effects and adverse effects : insights from molecular genetics[J]. Hypertension, 2009, 54(2): 196-202.
[17]
Ayvaz G, Balos T？rüner F, Karakoc A, et al. Acute and chronic effects of different concentrations of free fatty acids on the insulin secreting function of islets[J]. Diabetes Metab, 2002, 28(6 Pt 2):3S7-12.
[18]
Fujiwara W, Izawa H, Ukai G, et al. Low dose of hydrochlorothiazide, in combination with angiotensin receptor blocker, reduces blood pressure effectively without adverse effect on glucose and lipid profiles[J]. Heart Vessels, 2012, Mar 25. [Epub ahead of print] DOI: 10.1007/s00380-012-0246-5.
[ 2 ] Safar M, Laurent S, Safavian A, et al. Sodium and large arteries in hypertension. Effects of indapamide[J]. Am J Med, 1988, 84(1B): 15-19.
[21]
[ 3 ] Safar ME, Asmar R, Benetos A, et al. Sodium, large arteries, and diuretic compounds in hypertension[J]. Am J Med Sci, 1994, 307( Suppl 1): 3-8.
[22]
[ 4 ] Matrougui K, Lévy BI, Schiavi P, et al. Indapamide improves flow-induced dilation in hypertensive rats with a high salt intake[J]. J Hypertens, 1998, 16(10): 1485-1490.
[23]
[ 5 ] Kool MJ, Lustermans FA, Breed JG, et al. The influence of perindopril and the diuretic combination amiloride + hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients[J]. J Hypertens, 1995, 13(8): 839-848.
[24]
[ 6 ] Girerd X, Giannattasio C, Moulin C, et al. Regression of radial artery wall hypertrophy and improvement of carotid artery compliance after long-term antihypertensive treatment in elderly patients[J]. J Am Coll Cardiol, 1998, 31(5): 1064-1073.
[25]
[ 7 ] Kithas PA, Supiano MA. Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension[J]. J Am Geriatr Soc, 2010, 58(7): 1327-1332.
[26]
[ 8 ] Winer N, Weber MA, Sowers JR. The effect of antihypertensive drugs on vascular compliance[J]. Curr Hypertens Rep, 2001, 3(4): 297-304.
Wald DS, Law M, Morris JK, et al. Combination therapy versus monotherapy in reducing blood pressure:meta-analysis of 11000 participants from 42 trials[J]. Am J Med, 2009, 122(3): 290-300.
[29]
Kang S, Wu YF, An N, et al. A systematic review and Meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertension[J]. Clin Ther, 2004, 26(2): 257-270.
[30]
Heran BS, Chen JM, Wang JJ, et al. Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertension[J]. Cochrane Database Syst Rev, 2010, 20(1): CD008167.
[31]
Sica DA, Carter B, Cushman W, et al. Thiazide and loop diuretics[J]. J Clin Hypertens, 2011, 13(9): 639-643.
[32]
Tropeano AI, Saleh N, Hawajri N, et al. Do all antihypertensive drugs improve carotid intima-media thickness A network meta-analysis of randomized controlled trials[J]. Fundam Clin Pharmacol, 2011, 25(3): 395-404.
[33]
Cherchi A, Sau F, Seguro C. Possible regression of left ventricular hypertrophy during antihypertensive treatment with diuretics and/or beta blockers[J]. J Clin Hypertens, 1987, 3(2): 216-225.
[34]
Raki D, Rumboldt Z, Bagatin J, et al. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study[J]. Croat Med J, 2002, 43(6): 672-679.
[35]
Papademetriou V, Gottdiener JS, Narayan P, et al. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: results of a multicenter trial. The Isradipine Study Group[J]. J Am Coll Cardiol, 1997, 30(7): 1802-1808.
[36]
Mottram PM, Haluska B, Leano R, et al. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure[J]. Circulation, 2004, 110(5): 558-565.
[37]
Mourad JJ, Le Jeune S. Evaluation of high dose of perindopril/indapamide fixed combination in reducing blood pressure and improving end-organ protection in hypertensive patients[J]. Curr Med Res Opin, 2009, 25(9): 2271-2280.
[38]
Bulpitt CJ, Beckett NS, Peters R, et al. Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET) [J]. J Hum Hypertens, 2012, 26(3): 157-163.
[39]
Beckett NS, Peters R, Flecher AE, et al. Treatment of hypertension in patients 80 years of age or older[J]. N Engl J Med, 2008, 358(18): 1887-1898.
[40]
SHEP Cooperative Reaserch Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension.Final results of the systolic hypertension in the elderly program (SHEP) [J]. JAMA, 1991, 265(24): 3255-3264.
